FDA Approves Methoxsalen USP Provider

Wednesday, February 29, 2012 | FDA Approval/Clearance

FDA has approved a secondary supplier of Methoxsalen USP, prescribed under the brand name Oxsoralen-Ultra® (methoxsalen) Capsules, USP, 10mg. Valeant Dermatology, a division of Valeant Pharmaceuticals North America LLC, and marketer of the drug announced the decision last month. Questions or concerns about product availability, can be directed to the Valeant Customer Care group at 1-800-556-1937 or via e-mail: pharmcs@valeant.com.

Next Story


You must be logged in to leave a comment.